Key points are not available for this paper at this time.
!Figure1 Here, we describe a 52-year-old woman with a history of primary plasma cell leukemia (PCL) who achieved complete remission after the tandem of autologous and nonmyeloablative allogeneic stem cell transplantation (SCT). Nine months after the allogeneic SCT, she presented with
Donk et al. (Thu,) studied this question.